Tim Kutzker
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.
Journal: Cancers
Published: October 31, 2023
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.
Journal: Journal of clinical medicine
Published: March 29, 2023
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.
Journal: Cancers
Published: January 12, 2023
Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13, 3830.
Journal: Cancers
Published: June 30, 2021
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
Journal: Cancers
Published: June 30, 2021
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: April 11, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026